PRA Health Sciences (PRAH) Tops Q3 EPS by 7c; Lifts FY15 EPS Outlook

PRA Health Sciences (NASDAQ: PRAH) reported Q3 EPS of $0.52, $0.07 better than the analyst estimate of $0.45. Revenue for the quarter came in at $345.1 million versus the consensus estimate of $346.05 million.

PRA Health Sciences sees FY2015 EPS of $1.89-$1.92, versus prior guidance of $1.75-$1.85 and the consensus of $1.81.

For earnings history and earnings-related data on PRA Health Sciences (PRAH) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• JD.com (JD) Reiterated at Buy by Benchmark Amid Earnings Recovery
• CaliberCos Inc (CWD) Misses Q2 EPS by 43c; Offers Guidance